REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanovelos S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Engineering Services | Administrative Management and General Management Consulting Services | Marketing Consulting Services | Scientific Research and Development Services
Full name: Nanovelos S.A. Profile Updated: February 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

NanoVelos is a pharmaceutical company that specializes in developing nanoparticle-based drug delivery systems and industrial research. Their services include formulation of medicinal substances, analysis of substance content, synthesis of compounds, and expert analysis. NanoVelos targets the pharmaceutical market and offers a range of services in this industry.

Headquarters
Ul. Rakowiecka 36
Warsaw; Mazowieckie; Postal Code: 02-532

Contact Details: Purchase the Nanovelos S.A. report to view the information.

Website: http://www.nanovelos.com

Basic Information
Total Employees:
Purchase the Nanovelos S.A. report to view the information.
Registered Capital:
Purchase the Nanovelos S.A. report to view the information.
Financial Auditors:
Purchase the Nanovelos S.A. report to view the information.
Incorporation Date:
October 30, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Nanovelos S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-29.69%
Total operating revenue
-98.46%
Operating Profit/Loss (EBIT)
78.9%
EBITDA
79.45%
Net Profit/Loss for the Period
75.98%
Total Assets
-24.44%
Total Equity
94.37%
Operating Profit Margin (ROS)
1981.08%
Net Profit Margin
1938.95%
Return on Equity (ROE)
503.57%
Quick Ratio
-0.85%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?